VELA
DEAD

Serial Number

85857854

Owner

VELA DIAGNOSTICS HOLDING PTE. LTD.

Attorney

Stacy L. Emhoff

First Use Date

Feb 18, 2013

Filing Date

Feb 22, 2013

Add to watchlist:

No watchlists yet
View on USPTO

VELA Trademark

Serial Number: 85857854 • Registration: 4848776

VELA is a trademark filed by VELA DIAGNOSTICS HOLDING PTE. LTD. on February 22, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

VELA DIAGNOSTICS HOLDING PTE. LTD.

50 SCIENCE PARK ROAD
SCIENCE PARK II 117406 , SG

Entity Type: 16

Vela Holding Pte. Ltd.

#02-04/05/06 The Kendall
Singapore 117406 , SG

Entity Type: 99

Trademark Details

Filing Date

February 22, 2013

Registration Date

November 10, 2015

First Use Anywhere

February 18, 2013

First Use in Commerce

February 18, 2013

Published for Opposition

March 17, 2015

Cancellation Date

May 22, 2026

Goods & Services

Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data

Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes, with none being apparatus or instruments for in cosmetic or aesthetic practice or procedures, or any products that involve respiratory testing, respiratory diagnostics or blood gas analyzers with the exception of products for the molecular diagnosis of pathogenic microorganisms, such as bacteria and viruses that may infect the respiratory tract

Scientific and technological services, namely, scientific research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software none being apparatus or instruments for use in cosmetic or aesthetic practice or procedures for the operation and maintenance of scientific apparatus, instruments and equipment; development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data, none of the services involve respiratory testing, respiratory diagnostics or blood gas analyzers with the exception of services for the molecular diagnosis of pathogenic microorganism, such as bacteria and viruses that my infect the respiratory tract

In-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes

Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; biological substances and chemicals used for medical scientific and medical research purposes, namely, reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
May 22, 2026 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 10, 2024 REM2
CANCELLED SECTION 18-PARTIAL
Oct 22, 2024 C18P
BOARD DECISION: COUNTERCLAIM GRANTED
Oct 22, 2024 TTCG
COUNTERCLAIM OPP. NO. 999999
Nov 2, 2023 CCON
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 2, 2021 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 2, 2021 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 2, 2021 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 27, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 10, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 10, 2015 R.PR
ASSIGNMENT OF OWNERSHIP UPDATED MANUALLY
Oct 20, 2015 AOUM
TTAB RELEASE CASE TO TRADEMARKS
Oct 1, 2015 TMBN
OPPOSITION TERMINATED NO. 999999
Oct 1, 2015 OP.T
OPPOSITION DISMISSED NO. 999999
Oct 1, 2015 OP.D
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 23, 2015 ASCK
ASSIGNED TO EXAMINER
Aug 24, 2015 DOCK
OPPOSITION INSTITUTED NO. 999999
May 29, 2015 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 8, 2015 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2015 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 12, 2015 PREV
ASSIGNED TO LIE
Feb 11, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 6, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 6, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 6, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 6, 2015 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 5, 2015 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 3, 2015 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 20, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 20, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 20, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 20, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 20, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 29, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 29, 2014 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 6, 2014 GPRN
PRIORITY ACTION E-MAILED
Oct 6, 2014 GPRA
PRIORITY ACTION WRITTEN
Oct 6, 2014 CPRA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 1, 2014 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 16, 2014 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 4, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 26, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 26, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 26, 2014 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2014 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2014 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 24, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 24, 2014 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 5, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 5, 2014 GNSL
SUSPENSION LETTER WRITTEN
Mar 5, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 14, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 14, 2014 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 7, 2014 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 7, 2014 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 7, 2014 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 3, 2014 RCCK
ASSIGNED TO LIE
Dec 27, 2013 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 7, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 7, 2013 GNSL
SUSPENSION LETTER WRITTEN
Jun 7, 2013 CNSL
ASSIGNED TO EXAMINER
Jun 6, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2013 NWOS
NEW APPLICATION ENTERED
Feb 26, 2013 NWAP